Table 1 Comparative demographic, clinical, and laboratory data of both groups

Age, years

52.65 ±10.60

51.57 ±11.82

0.432

Males

87 (30.7%)

196 (69.3%)

0.821

Hypertension

18 (25%)

54 (75%)

0.163

Diabetes mellitus

58 (39.7%)

88 (60.3%)

0.003

Proton pump inhibitors

18 (25%)

54 (75%)

0.163

B-blockers

22 (32.4%)

46 (67.6%)

0.904

Total bilirubin, mg/dL

2.61 ±2.4

2.40 ±3.6

0.386

Albumin, g/dL

2.46 ±0.49

2.52 ±0.52

0.237

AST, U/L

89.30 ±72.62

79.24 ±67.94

0.181

ALT, U/L

53.04 ±40.65

51.73 ±42.17

0.772

Urea, mg/dL

109.78 ±72.02

102.94 ±78.10

0.408

Creatinine, mg/dL

1.88 ±1.51

1.60 ±1.5

0.065

Sodium, mmol/L

128 ±8

129 ±7

0.030

Hemoglobin, g/dL

10.10 ±2.75

10.50 ±2.3

0.597

WBCs, ×103/μL

9.55 ±5.85

9.20 ±5.6

0.300

Platelets, ×103/μL

101.50 ±55

102.00 ±69

0.955

CTP score

9.7±2.5

9.6±2.2

0.630

AFPC baseline, cell/mm³

975 ±1445

1000 ±1380

0.419

AFPC 24h, cell/mm³

1100 ±1700

800 ±970

0.001

AFPC 24h percent drop

−10.17 ±35

−28.09 ±24

0.001

AFPC 24h ≥25% drop

16 (9.4%)

154 (90.6%)

0.001

AFPC 48h, cell/mm³

900 ±1590

500 ±630

0.001